Cabaletta Bio, Inc. (CABA) Financials

$1.19

south_east
-$0.02 (-1.65%)
Day's range
$1.17
Day's range
$1.27
$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80M-$100M-$100M-$120M-$120MEarning201820182019201920202020202120212022202220232023202420246%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

CABA Income statement / Annual

Last year (2024), Cabaletta Bio, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Cabaletta Bio, Inc.'s net income was -$115.86 M. See Cabaletta Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $1.43 M $3.68 M $733,000.00 $354,000.00 $104,000.00 $0.00 $0.00
Gross Profit $0.00 -$1.43 M -$3.68 M -$733,000.00 -$354,000.00 -$104,000.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0
Research and Development Expenses $97.20 M $55.42 M $39.30 M $32.49 M $21.38 M $11.67 M $4.47 M $0.00
General & Administrative Expenses $27.94 M $19.24 M $14.84 M $13.82 M $12.46 M $7.01 M $1.73 M $333,333.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$83,333.00
Selling, General & Administrative Expenses $27.94 M $19.24 M $14.84 M $13.82 M $12.46 M $7.01 M $1.73 M $250,000.00
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$6.24 M $0.00
Operating Expenses $125.14 M $74.66 M $54.14 M $46.31 M $33.83 M $18.68 M $6.19 M $250,000.00
Cost And Expenses $0.00 $74.66 M $54.14 M $46.31 M $33.83 M $18.68 M $6.19 M $250,000.00
Interest Income $10.03 M $6.99 M $1.16 M $24,000.00 $494,000.00 $1.74 M $235,000.00 $0.00
Interest Expense -$748,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization -$8.53 M $1.43 M $3.68 M $733,000.00 $354,000.00 $104,000.00 $6.19 M $333,333.00
EBITDA -$125.14 M -$73.23 M -$52.96 M -$45.58 M -$33.48 M -$18.68 M -$6.01 M $83,333.00
EBITDA Ratio 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $9.28 M $6.99 M $1.16 M $24,000.00 $494,000.00 $1.74 M -$6.01 M $83,333.00
Income Before Tax -$115.86 M -$67.68 M -$52.98 M -$46.29 M -$33.34 M -$16.94 M -$12.20 M -$250,000.00
Income Before Tax Ratio 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $0.00 -$1.16 M -$757,000.00 -$848,000.00 -$1.84 M -$235,000.00 -$333,333.00
Net Income -$115.86 M -$67.68 M -$51.81 M -$45.53 M -$32.49 M -$15.10 M -$12.20 M -$250,000.00
Net Income Ratio 0 0 0 0 0 0 0 0
EPS -2.37 -1.65 -1.77 -1.77 -1.4 -0.63 -0.84 -0.0104
EPS Diluted -2.34 -1.65 -1.77 -1.77 -1.4 -0.63 -0.84 -0.0104
Weighted Average Shares Out $49.52 M $40.95 M $29.34 M $25.74 M $23.15 M $24.03 M $14.51 M $24.03 M
Weighted Average Shares Out Diluted $49.47 M $40.95 M $29.34 M $25.74 M $23.15 M $24.03 M $14.51 M $24.03 M
Link